SDL, Johns Hopkins Aramco Healthcare to Advance Diagnostic, Genetic Testing

   Riyadh, October 30, 2025, SPA -- Saudi Diagnostic Limited (SDL), a subsidiary of King Faisal Specialist Hospital International (KFSHI) Holding Company, signed a memorandum of understanding (MoU) with Johns Hopkins Aramco Healthcare (JHAH) to explore cooperation in advanced diagnostic and genetic testing, in a step aimed at strengthening the diagnostics ecosystem in the Kingdom.
   The MoU provides for developing high-quality reference laboratory services, expanding national expertise in molecular genetics, and cooperating on knowledge transfer, training, and quality assurance in line with international standards.
   The cooperation extends both parties’ commitment to precision medicine and supports Saudi Vision 2030 by localizing advanced health technologies and improving the quality of patient care.
   KFSHI is the commercial and investment arm of King Faisal Specialist Hospital and Research Centre (KFSHRC). It oversees a portfolio of subsidiaries that contribute to developing healthcare services, advancing research innovation, and enhancing operational sustainability inside and outside the Kingdom.
   -- SPA